Especially given how quickly we are trying to develop a COVID-19 vaccine, it’s a good sign that the AstraZeneca trial paused to investigate an unexplained illness, commented Susan Ellenberg, PhD.

Susan Ellenberg, PhD, comments on the state of COVID-19 vaccine development: She hopes people are reassured by the AstraZeneca trial's pause for safety and says it's unlikely that we’ll have a vaccine this fall.

New COVID-19 infections were about 30 percent lower in counties where the highest number of people stopped going in to their offices for work, found research led by Joshua Baker, MD, MSCE.

When we’re offered a COVID-19 vaccine, we should ask: Does it protect people, without causing major toxicities or health problems? If so—and after the FDA and its expert committees review— “I will certainly be in line to get one," Susan Ellenberg, PhD, commented on the radio show Ask an Expert.